Parma, Italy

Antonio Caligiuri

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2013-2014.


% Patents Active = 66.7

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Antonio Caligiuri: Innovator in Medicinal Chemistry

Introduction

Antonio Caligiuri is a prominent inventor based in Parma, Italy. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on alkaloid aminoester derivatives. With a total of 3 patents to his name, Caligiuri's inventions focus on therapeutic applications that address critical health issues.

Latest Patents

Caligiuri's latest patents include groundbreaking work on alkaloid aminoester derivatives and their medicinal compositions. One of his notable inventions involves alkaloid aminoester compounds that act as muscarinic receptor antagonists, which are useful for the prevention and treatment of broncho-obstructive or inflammatory diseases. Another patent elaborates on the processes for preparing these compounds, their compositions, and their therapeutic uses, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Antonio Caligiuri has been associated with Chiesi Farmaceutici S.p.a., a leading pharmaceutical company. His work there has allowed him to focus on developing innovative solutions that can significantly impact patient care and treatment options.

Collaborations

Caligiuri has collaborated with esteemed colleagues such as Mauro Riccaboni and Gabriele Amari. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Antonio Caligiuri stands out as a dedicated inventor in the field of medicinal chemistry. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…